California Public Employees Retirement System’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-107,408
| Closed | -$18.5M | – | 1243 |
|
|
2021
Q3 | $18.5M | Sell |
107,408
-899
| -0.8% | -$118K | 0.01% | 696 |
|
|
2021
Q2 | $13.6M | Sell |
108,307
-3,688
| -3% | -$465K | 0.01% | 864 |
|
|
2021
Q1 | $15.2M | Sell |
111,995
-6,058
| -5% | -$783K | 0.01% | 810 |
|
|
2020
Q4 | $15.1M | Buy |
118,053
+273
| +0.2% | +$32K | 0.01% | 786 |
|
|
2020
Q3 | $13.3M | Buy |
117,780
+14,888
| +14% | +$1.48M | 0.01% | 733 |
|
|
2020
Q2 | $9.8M | Buy |
102,892
+2,610
| +3% | +$252K | 0.01% | 810 |
|
|
2020
Q1 | $9.01M | Sell |
100,282
-2,050
| -2% | -$159K | 0.01% | 726 |
|
|
2019
Q4 | $5.43M | Buy |
102,332
+18,998
| +23% | +$866K | ﹤0.01% | 1400 |
|
|
2019
Q3 | $3.29M | Buy |
83,334
+21,072
| +34% | +$914K | ﹤0.01% | 1560 |
|
|
2019
Q2 | $2.56M | Buy |
62,262
+648
| +1% | +$26.8K | ﹤0.01% | 1551 |
|
|
2019
Q1 | $2.87M | Sell |
61,614
-900
| -1% | -$39.5K | ﹤0.01% | 1540 |
|
|
2018
Q4 | $2.72M | Sell |
62,514
-5,500
| -8% | -$275K | ﹤0.01% | 1502 |
|
|
2018
Q3 | $3.89M | Sell |
68,014
-4,700
| -6% | -$231K | 0.01% | 1465 |
|
|
2018
Q2 | $3.53M | Buy |
72,714
+51,414
| +241% | +$1.87M | ﹤0.01% | 1527 |
|
|
2018
Q1 | $833K | Sell |
21,300
-1,000
| -4% | -$42.5K | ﹤0.01% | 2380 |
|
|
2017
Q4 | $946K | Buy |
22,300
+1,400
| +7% | +$52.5K | ﹤0.01% | 2353 |
|
|
2017
Q3 | $780K | Hold |
20,900
| – | – | ﹤0.01% | 2442 |
|
|
2017
Q2 | $635K | Hold |
20,900
| – | – | ﹤0.01% | 2530 |
|
|
2017
Q1 | $553K | Sell |
20,900
-1,000
| -5% | -$26.4K | ﹤0.01% | 2609 |
|
|
2016
Q4 | $559K | Sell |
21,900
-200
| -0.9% | -$6.34K | ﹤0.01% | 2644 |
|
|
2016
Q3 | $800K | Sell |
22,100
-1,700
| -7% | -$56.3K | ﹤0.01% | 2483 |
|
|
2016
Q2 | $809K | Sell |
23,800
-600
| -2% | -$19.5K | ﹤0.01% | 2472 |
|
|
2016
Q1 | $644K | Sell |
24,400
-1,500
| -6% | -$43.6K | ﹤0.01% | 2603 |
|
|
2015
Q4 | $1.26M | Hold |
25,900
| – | – | ﹤0.01% | 2235 |
|
|
2015
Q3 | $645K | Hold |
25,900
| – | – | ﹤0.01% | 2642 |
|
|
2015
Q2 | $819K | Sell |
25,900
-9,102
| -26% | -$294K | ﹤0.01% | 2625 |
|
|
2015
Q1 | $1.43M | Hold |
35,002
| – | – | ﹤0.01% | 2340 |
|
|
2014
Q4 | $1.43M | Buy |
+35,002
| New | +$1.22M | ﹤0.01% | 2340 |
|
California Public Employees Retirement System's XLRN Position: Q4 2021 in Review
California Public Employees Retirement System sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 107,408 shares — an estimated $18.5M sold.
California Public Employees Retirement System first reported a position in XLRN in Q4 2014 and held it in 28 quarters. The position peaked at $18.5M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- California Public Employees Retirement System reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- California Public Employees Retirement System sold 107,408 Acceleron Pharma shares in Q4 2021, an estimated $18.5M.
- California Public Employees Retirement System first reported a position in Acceleron Pharma in Q4 2014 and held it in 28 quarters.
- California Public Employees Retirement System's Acceleron Pharma position peaked at $18.5M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on California Public Employees Retirement System's 13F filing for Q4 2021, filed 10 Feb 2022.